Principal Investigator
Lynn Feun
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231324
Clinical Trial Summary
Phase 2, Single Arm Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Cutaneous Malignancies
Contact Information
Phone Number
305-243-2647